PL
BIO icon

Parkwood LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Parkwood LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,644
Closed -$7.63M – 192
2023
Q4 		$7.63M Buy
+23,644
New +$7.41M 0.91% 34
2016
Q4 		– Sell
-3,248
Closed -$532K – 497
2016
Q3 		$532K Hold
3,248
– – 0.08% 196
2016
Q2 		$465K Sell
3,248
-562
-15% -$80.2K 0.08% 269
2016
Q1 		$521K Buy
3,810
+561
+17% +$73.6K 0.09% 280
2015
Q4 		$451K Buy
3,249
+1,090
+50% +$151K 0.07% 302
2015
Q3 		$290K Hold
2,159
– – 0.05% 372
2015
Q2 		$325K Buy
+2,159
New +$309K 0.05% 281
2014
Q1 		– Sell
-1,495
Closed -$185K – 191
2013
Q4 		$185K Buy
+1,495
New +$182K 0.05% 268

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Parkwood LLC's BIO Position: Q1 2024 in Review

Parkwood LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2024, closing a stake of 23,644 shares — an estimated $7.63M sold.

Parkwood LLC first reported a position in BIO in Q4 2013 and held it in 8 quarters. The position peaked at $7.63M in Q4 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • Parkwood LLC reported no remaining Bio-Rad Laboratories Class A position as of Q1 2024 after selling out during the quarter.
  • Parkwood LLC sold 23,644 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $7.63M.
  • Parkwood LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2013 and held it in 8 quarters.
  • Parkwood LLC's Bio-Rad Laboratories Class A position peaked at $7.63M in Q4 2023.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Parkwood LLC's 13F filing for Q1 2024, filed 15 May 2024.